Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma - Toni K. Choueiri; Robert J. Motzer; Jose A. Karam; Wesley Yip; Cristina Suarez; Dingwei Ye; Zhisong He; Christian Caglevic; Tom Ferguson; Yen-Hwa Chang; Carlos Rojas; Roberto Iacovelli; et al. (New England Journal of Medicine, 2026)